# An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms

> **NCT00893113** · PHASE3 · COMPLETED · sponsor: **Chesapeake Urology Research Associates** · enrollment: 74 (actual)

## Conditions studied

- Erectile Dysfunction
- Lower Urinary Tract Symptoms

## Interventions

- **DRUG:** Placebo
- **DRUG:** Alfuzosin

## Key facts

- **NCT ID:** NCT00893113
- **Lead sponsor:** Chesapeake Urology Research Associates
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2018-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00893113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00893113, "An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00893113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*